PD43 Efficacy And Safety Of Therapeutic Strategies For Human Brucellosis: A Systematic Review And Network Meta-Analysis
Endi Lanza Galvão, Gláucia Cota, Moisés Gonçalves, Marina Fonseca-Souza, Diego Mendes Xavier, Glaciele Maria de Souza, Sarah Nascimento Silva · 2025
Read PD43 Efficacy And Safety Of Therapeutic Strategies For Human Brucellosis: A Systematic Review And Network Meta-Analysis by Endi Lanza Galvão, Gláucia Cota, Moisés Gonçalves, Marina Fonseca-Souza, Diego Mendes Xavier, Glaciele Maria de Souza, Sarah Nascimento Silva (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768807.txt.
Description
Endi Lanza Galvão and co-authors wrote a 2025 review that compares drug plans for human brucellosis, a germ disease people catch from animals. The illness causes long fever, tiredness, and weight loss, and it can drag on for months. Plans that pair two or more drugs work better than a single drug, but the best pair has been unclear.
The team searched four large health databases for trials that tested drug plans in patients. They weighed how often each plan failed, how fast fever broke, and what side effects showed up. Their method lets many plans be compared at once, even when trials did not test them head to head. The results feed into new care guides for the disease in Brazil. The review gives doctors a firmer base for picking a drug plan.
Catalog record
| CREATOR | Endi Lanza Galvão, Gláucia Cota, Moisés Gonçalves, Marina Fonseca-Souza, Diego Mendes Xavier, Glaciele Maria de Souza, Sarah Nascimento Silva |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |